KUNG ROBERT T V 4

Accession 0001179110-06-006787

CIK 0000815094other

View on SEC.gov Company Profile

Filed

Mar 20, 7:00 PM ET

Accepted

Mar 21, 7:46 AM ET

Size

26.8 KB

Accession

0001179110-06-006787

Insider Transaction Report

Form 4

Period: 2006-03-20

ABIOMED INCABMD

KUNG ROBERT T V

SVP, Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock, $.01 par value
2006-03-20$6.25/sh+7,000$43,750→ 7,000 total
Sale
Common Stock, $.01 par value
2006-03-20$12.03/sh−17,000$204,427→ 0 total
Exercise/Conversion
Common Stock, $.01 par value
2006-03-20$5.75/sh+10,000$57,500→ 17,000 total
Exercise/Conversion
Stock Option (right to buy)
2006-03-20$5.75/sh−10,000$57,500→ 0 total
Exercise: $5.75From: 2002-05-27Exp: 2007-05-27→ Common Stock (10,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2006-03-20$6.25/sh−7,000$43,750→ 0 total
Exercise: $6.25From: 2001-08-12Exp: 2006-08-12→ Common Stock (7,000 underlying)

Holdings

Stock Option (right to buy)
Exercise: $6.75From: 2004-06-25Exp: 2012-06-25→ Common Stock (50,000 underlying)
50,000
Stock Option (right to buy)
Exercise: $6.69From: 2001-07-01Exp: 2009-07-01→ Common Stock (20,000 underlying)
20,000
Stock Option (right to buy)
Exercise: $5.11From: 2005-06-25Exp: 2013-06-25→ Common Stock (16,000 underlying)
16,000
Common Stock, $.01 par value
(indirect: By Trust)
100,200
Stock Option (right to buy)
Exercise: $6.81From: 2003-07-01Exp: 2008-07-01→ Common Stock (40,000 underlying)
40,000
Common Stock, $.01 par value
(indirect: By Trust)
87,060
Common Stock, $.01 par value
(indirect: By Trust)
16,968

Footnotes (13)

[F1]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1992 Combination Stock Option Plan.
[F10]These shares are held in trust for the benefit of the reporting person's spouse.
[F11]Thirty percent of this option will become exercisable on each of 6/25/05 and 6/25/06 and an addtional 40 percent will become exercisable on 6/25/07.
[F12]These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
[F13]Stock was acquired and sold pursuant to a Sales Plan compliant with the requirements of SEC Rule 10b5-1.
[F2]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1998 Equity Incentive Plan.
[F3]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
[F4]Options were fully exercisable on the date shown.
[F5]Thirty percent of this option will become exercisable on each of 7/1/01 and 7/1/02 and an addtional 40 percent will become exercisable on 7/1/03
[F6]Thirty percent of this option will become exercisable on each of 6/28/02 and 6/28/03 and an addtional 40 percent will become exercisable on 6/28/04.
[F7]Thirty percent of this option will become exercisable on each of 6/22/03 and 6/22/04 and an addtional 40 percent will become exercisable on 6/22/05.
[F8]Thirty percent of this option will become exercisable on each of 6/25/04 and 6/25/05 and an addtional 40 percent will become exercisable on 6/25/06.
[F9]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

ABIOMED INC

CIK 0000815094

→

Entity typeother

Related Parties

filerCIK 0001203037

Filing Metadata

Form type: 4
Filed: Mar 20, 7:00 PM ET
Accepted: Mar 21, 7:46 AM ET
Size: 26.8 KB

View on SEC.gov